In 1992, Brugada syndrome (BS) was first described; an often unrecognized cardiac
conduction disorder mainly associated with unexplained sudden cardiac arrest and …

Brugada syndrome is an inherited cardiac arrythmia causes sudden death usually
associated with loss-of-function mutations of SCN5A, a gene encodes α subunit of cardiac …

Background: Brugada Syndrome (BrS) is a rare genetic disorder with specific ECG patterns
carrying an increased risk of sudden cardiac death. Case Presentation: We present a 36 …

Brugada syndrome (BrS) is an inherited arrhythmogenic disorder predisposing patients to a
high risk of sudden cardiac death. Specific guidelines on the health surveillance of BrS …

Rare diseases affect approximately 30 million Americans, but fewer than one in 10 of these
patients receive an accurate diagnosis and timely, appropriate treatment. Many of these …

Abstract Coronavirus disease (COVID-19) is an illness that was sudden, unexpected, and
global. Primarily a disease of the vascular endothelium, the virus threatens all of core …

Objective: Despite its widespread use and safety data, the cardiac safety of lamotrigine was
brought into question in October 2020 when the US Food and Drug Administration issued a …

Brugada syndrome (BrS) is characterized by ST segment elevations in the right precordial
leads, V1-V3, with additional findings of ventricular arrhythmias and family history (FH) of …

Brugada syndrome (BrS) may cause a spectrum of symptoms from asymptomatic patients to
those who experience cardiac arrest and sudden cardiac death. The diagnosis is confirmed …

Brugada syndrome is a hereditary cardiac sodium channelopathy that is autosomal
dominant. Despite having a structurally normal heart, people with Brugada syndrome have …